insights_auto
Why is IPSEY up 2.46%?
Dive Deeperchevron_right
IPSEY:OTCMKTS
Ipsen ADR Rep 1/4 Ord Shs
$41.90
arrow_upward
+2.46%(+1.01) 1D
Sep 30, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IPSEY...
Open
$41.90
High
$41.90
Low
$41.90
Mkt. cap
11.91B
Avg. vol.
517.00
Volume
171.00
52-wk high
$51.10
52-wk low
$32.68
Beta
0.41
Shares outstanding
335.26M
No. of employees
6K
Open
$41.90
High
$41.90
Low
$41.90
Mkt. cap
11.91B
Avg. vol.
517.00
Volume
171.00
52-wk high
$51.10
52-wk low
$32.68
Beta
0.41
Shares outstanding
335.26M
No. of employees
6K
News stories
From web sources and news partners
Yahoo Finance UK
·
2 days ago
GENFIT Reports First-Half 2026 Financial Results and Provides Corporate Update
Profile
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines are registered in 88 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world. Ipsen has been a family-owned business for the past 90 years and is publicly traded on the Euronext Paris as part of the SBF 120 index. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Wikipedia
About Ipsen ADR Rep 1/4 Ord Shs